D.E. Shaw & Co’s Ambrx Biopharma Inc AMAM Stock Holding History

D.E. Shaw & Co’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,240,486	Closed	-$60.4M	–	4881
2023 Q4	$60.4M	Buy	4,240,486 +235,973	+6%	+$2.68M	0.05%	413
2023 Q3	$46.1M	Sell	4,004,513 -11,395	-0.3%	-$155K	0.05%	459
2023 Q2	$66.1M	Buy	4,015,908 +82,356	+2%	+$1.04M	0.07%	347
2023 Q1	$35.1M	Buy	+3,933,552	New	+$19.8M	0.04%	585

D.E. Shaw & Co's AMAM Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 4,240,486 shares — an estimated $60.4M sold.

D.E. Shaw & Co first reported a position in AMAM in Q1 2023 and held it in 4 quarters. The position peaked at $66.1M in Q2 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

D.E. Shaw & Co reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
D.E. Shaw & Co sold 4,240,486 Ambrx Biopharma Inc shares in Q1 2024, an estimated $60.4M.
D.E. Shaw & Co first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 4 quarters.
D.E. Shaw & Co's Ambrx Biopharma Inc position peaked at $66.1M in Q2 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.